|
| Trials | Sample size | Gender | Age (yr) | Intervention | Outcome measure | Balance report of baseline |
| Experimental group | Control group | Period |
|
| Fu (2006) [36] | 83 (44/39) | (19 M : 25 F)/(17 M : 22 F) | 45–65/43–66 | Modified Banxiaxiexin decoction (300 mL/d) | Domperidone (10 mg, tid) | 9 W | Clinical effective rate Gastric emptying test | Not mentioned |
|
| Gao (2011) [37] | 67 (35/32) | (21 M : 14 F)/(17 M : 15 F) | 34–72 (54)/37–71 (56) | Modified Banxiaxiexin decoction, bid | Domperidone (10 mg, tid) | 8 W | Clinical effective rate Gastric emptying test | |
|
| Li (2004) [38] | 85 (45/40) | (28 M : 17 F)/(28 M : 12 F) | 50–72 | Modified Banxiaxiexin decoction (400 mL/d) | Domperidone (10 mg, tid) | 4 W | Clinical effective rate GI symptoms | Not mentioned |
|
| Liu et al. (2008) [39] | 76 (38/38) | (36 M : 40 F) | | Concentrated Banxiaxiexin decoction, bid | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | Not mentioned |
|
| Liu (2012) [40] | 120 (60/60) | (58 M : 62 F) | | Concentrated Banxiaxiexin decoction, bid plus Domperidone (10 mg, tid) | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | |
|
| Luo et al. (2008) [41] | 92 (46/46) | (25 M : 21 F)/(24 M : 22 F) | / | Modified Banxiaxiexin decoction, bid plus Mosapride (5 mg tid) | Mosapride (5 mg tid) | 4 W | Clinical effective rate Gastric emptying test GI symptoms Adverse events | |
|
| Qiu et al. (2004) [42] | 65 (35/30) | (19 M : 16 F)/(17 M : 13 F) | 43–75/42–73 | Modified Banxiaxiexin decoction, bid plus Cisapride (5 mg, tid) | Cisapride (5 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | No significant differences |
|
| Sun (2009) [43] | 96 (51/45) | (24 M : 27 F)/(18 M : 27 F) | 38–69/35–72 | Concentrated Banxiaxiexin decoction, bid | Domperidone (20 mg, tid) | 2 W | Clinical effective rate Gastric emptying test GI symptoms | |
|
| Wang (2011) [44] | 100 (50/50) | (24 M : 26 F)/(25 M : 25 F) | 39–68/38–70 | Modified Banxiaxiexin decoction (300 mL/d) | Domperidone (10 mg, tid) | 2 W | Clinical effective rate Gastric emptying test GI symptoms | |
|
| Wang (2011) [45] | 56 (30/26) | (18 M : 12 F)/(15 M : 11 F) | /
| Modified Banxiaxiexin decoction (300 mL/d) | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test GI symptoms | |
|
| Wang (2010) [46] | 96 (48/48) | (22 M : 26 F)/(24 M : 24 F) | /
| Modified Banxiaxiexin decoction (300 mL/d) | Domperidone (10 mg, tid) plus Roxithromycin (150 mg bid) | 4 W | Clinical effective rate Gastric emptying test | |
|
| Yin (2012) [47] | 110 (57/53) | (35 M : 22 F)/(30 M : 23 F) | /
| Concentrated Banxiaxiexin decoction, bid | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | |
|
| Zhou (2003) [48] | 72 (48/24) | (20 M : 28 F)/ (11 M : 13 F) | 38–64 (56.2)/36–63 (56.1) | Modified Banxiaxiexin decoction, bid | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | |
|
| Zhou (2005) [49] | 86 (43/43) | (20 M : 23 F)/(19 M : 24 F) | /
| Modified Banxiaxiexin decoction, bid | Cisapride (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test, FBG | |
|
|
Zhu and Ji (2009) [50] | 50 (26/24) | (14 M : 12 F)/(11 M : 13 F) | 38–64 (56.2)/36–63 (56.1) | Modified Banxiaxiexin decoction, bid | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test | |
|
| Zou (2009) [51] | 48 (24/24) | (14 M : 10 F)/(13 M : 11 F) | /
| Modified Banxiaxiexin decoction (200 mL/d) | Domperidone (10 mg, tid) | 4 W | Clinical effective rate Gastric emptying test, FBG | |
|
